Statistical Analysis Supports Renal Denervation for Treating Hypertension Across Age Groups
May 9, 2013—The Society of Cardiovascular Angiography and Interventions (SCAI) announced the presentation of data suggesting that catheter-based renal denervation is projected to improve blood pressure and substantially reduce the incidence of major cardiovascular events in patients whose high blood pressure has not been sufficiently lowered with medications. Lead Investigator Jan Pietzsch, PhD, presented the findings at the SCAI 2013 scientific sessions in Orlando, Florida.
Study Supports Stent-Assisted Coiling of Intracranial Aneurysms
May 1, 2013—Findings from an analysis of stent-assisted coiling of intracranial aneurysms in 508 patients at a single center were published by Nohra Chalouhi, MD, et al in Stroke (2013;44:1348–1353).
Spectranetics Finalizes EXCITE ISR Adjunct Analysis Plan
May 6, 2013—Spectranetics Corporation (Colorado Springs, CO) announced that the US Food and Drug Administration (FDA) has approved the company’s adjunct analysis plan associated with the EXCITE ISR clinical trial, which is studying the treatment of in-stent restenosis (ISR) in the legs. The company stated that the goal of the adjunct analysis plan is to demonstrate statistically significant clinical superiority of laser atherectomy plus balloon percutaneous transluminal angioplasty (PTA) compared with PTA alone before full enrollment of the EXCITE ISR study.
Study Examines Associations of MRI-Measured SFA Occlusions With Functional Performance and Collateral Vessel Number in PAD
May 6, 2013—The Journal of the American College of Cardiology (JACC): Cardiovascular Imaging announced the publication online ahead of print of a study by Mary M. McDermott, MD, et al of the associations of magnetic resonance imaging (MRI)-measured superficial femoral artery (SFA) occlusions with functional performance, leg symptoms, and collateral vessel number in peripheral artery disease (PAD). The investigators studied associations of collateral vessel number with functional performance in PAD.